PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$1.84+0.11 (+6.36%)

Close on Oct 19, 2026

Market cap: $571.61M
P/E (TTM): –
Dividend yield: 0.00%

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	64	58	180	328	466	86	34	34	24	21	38	36	26	47	59	148	89	78
Short-Term Investments	216	335	452	447	584	237	19	84	46	55	49	65	86	54	119	136	–	–
Cash & Short-Term Investments	280	392	631	776	1,049	323	53	102	63	72	87	101	113	101	177	284	89	78
Receivables	35	28	37	19	24	17	15	8.60	13	11	5.25	3.41	2.75	2.82	4.56	0.34	–	–
Inventory	49	59	57	50	25	14	13	18	23	16	11	11	10	9.59	16	6.86	–	–
Prepaid Expenses & Other	11	19	17	10	7.39	4.87	3.07	2.83	2.25	9.98	12	1.67	1.14	2.01	2.09	2.24	–	–
Other Current Assets	–	–	–	–	–	–	–	–	0.93	0.48	0.74	0.11	–	–	–	–	–	–
Total Current Assets	375	496	742	852	1,101	356	81	132	102	109	111	118	126	115	200	293	–	–
Property, Plant & Equipment	24	31	36	42	33	25	30	34	38	15	8.55	6.60	9.24	14	18	12	–	–
Gross Property, Plant & Equipment	117	112	111	107	89	75	74	71	70	52	42	37	35	35	34	–	–	–
Accumulated Depreciation	-92	-82	-75	-65	-56	-50	-44	-37	-32	-37	-34	-30	-26	-21	-15	–	–	–
Construction in Progress	–	–	–	–	–	–	–	–	–	5.80	–	–	–	–	–	–	–	–
Long-Term Investments	–	–	96	70	122	21	–	1.49	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	42	16	33	40	47	30	33	36	–	–	–	–	–	–	–	–	–	–
Goodwill	318	318	462	410	410	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	15	390	457	410	411	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	8.77	9.31	13	11	1.17	0.04	0.04	0.04	0.05	9.81	7.52	0.03	0.49	0.35	0.32	0.32	–	–
Total Assets	784	1,260	1,746	1,767	2,007	414	148	170	144	138	131	124	136	130	218	306	–	–
Accounts Payable	21	17	15	12	11	3.58	8.37	6.74	9.09	8.36	4.75	5.61	1.72	2.99	4.74	9.52	–	–
Accrued Expenses	34	23	46	33	36	17	13	13	13	17	16	11	7.91	–	–	–	–	–
Short-Term Debt	–	0	0.49	1.84	1.61	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	0.17	0.14	0.11	–	–
Current Debt	–	0	0.49	1.84	1.61	–	–	–	–	–	–	–	–	0.17	0.14	0.11	–	–
Current Portion of Leases	0.45	10	9.59	8.89	7.71	4.33	3.84	3.40	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	16	14	16	30	11	8.72	7.61	6.54	–	–	–	–	–	3.38	4.24	3.22	–	–
Other Current Liabilities	2.03	3.22	8.33	7.23	5.76	4.52	0.23	0.79	0.61	1.68	0.24	1.53	2.10	8.20	10	–	–	–
Total Current Liabilities	73	66	95	263	72	39	49	27	29	34	38	31	23	15	19	21	–	–
Long-Term Debt	–	–	–	0.50	2.30	–	–	15	14	16	15	14	13	2.61	2.79	2.93	–	–
Long-Term Leases	57	15	32	41	50	38	42	46	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	57	25	41	50	58	42	46	49	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0	0.55	0.75	1.30	3.47	0.75	–	–	–	1.66	1.39	2.15	3.52	2.15	3.08	–	–	–
Total Liabilities	779	754	1,045	1,204	1,216	78	93	56	58	53	58	69	67	20	27	26	–	–
Total Debt	–	0	0.49	2.34	3.91	–	–	15	14	16	15	14	13	2.79	2.93	3.04	–	–
Preferred Stock	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Common Stock	0.30	0.29	0.27	0.23	0.22	0.19	0.15	0.15	0.12	0.09	0.08	0.07	0.07	0.06	633	0.05	–	–
Additional Paid-In Capital	2,700	2,655	2,540	2,100	2,010	1,372	1,121	1,096	966	872	787	736	684	645	–	612	–	–
Retained Earnings	-2,695	-2,149	-1,839	-1,532	-1,218	-1,037	-1,066	-982	-880	-788	-713	-681	-615	-536	-442	-332	–	–
Comprehensive Income & Other	0.46	0.42	0.22	-4.77	-1.09	0.09	0.01	-0.04	-0.03	0.01	-0.01	0.01	0.01	0.03	0.06	-0.02	–	–
Shareholders' Equity	5.35	507	701	563	791	335	55	114	86	85	74	55	69	109	191	280	-177	-93
Total Equity	5.35	507	701	563	791	335	55	114	86	85	74	55	69	109	191	280	-177	-93
Total Liabilities & Equity	784	1,260	1,746	1,767	2,007	414	148	170	144	138	131	124	136	130	218	306	–	–
Shares Outstanding(shares)	302	294	268	227	221	192	153	150	116	93	80	74	66	56	0.05	53	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 36.4%
Operating margin: -83.5%
Net margin: -82.5%
Return on equity, FY2025: -213.5%

Financial strength

Current ratio: 4.92
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 88.7%

Valuation

P/E ratio: –
Price to sales: 3.59
Price to book: –
Dividend yield: 0.00%